UMDARZY Priority claimed from 06/11/2023; Application No. : 98257354 ;United States of America
Goods or services claimed
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; Therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes.
Similar marks in class 5, same issue
- IMCLISFA Priority claimed from 06/11/2023; Application No. : 98257351 ;United States of America similar · Ideaya Biosciences, Inc.
- DANZITEN Priority claimed from 12/01/2024; Application No. : 98354233 ;United States of America similar · Azurity Pharmaceuticals, Inc.
- RINTIVA Priority claimed from 09/04/2024; Application No. : 98490960 ;United States of America similar · Azurity Pharmaceuticals, Inc.
Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.
What "advertised" means for UMDARZY Priority claimed from 06/11/2023; Application No. : 98257354 ;United States of America
Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.
Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.